SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-180669
Filing Date
2015-05-11
Accepted
2015-05-11 07:41:23
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d896623d10q.htm 10-Q 191929
2 EX-31.1 d896623dex311.htm EX-31.1 9005
3 EX-31.2 d896623dex312.htm EX-31.2 9006
4 EX-32.1 d896623dex321.htm EX-32.1 4448
5 EX-32.2 d896623dex322.htm EX-32.2 4449
  Complete submission text file 0001193125-15-180669.txt   2287416

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20150331.xml EX-101.INS 192177
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20150331.xsd EX-101.SCH 29166
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20150331_cal.xml EX-101.CAL 34650
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20150331_def.xml EX-101.DEF 171616
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20150331_lab.xml EX-101.LAB 235116
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20150331_pre.xml EX-101.PRE 203917
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 15848872
SIC: 2834 Pharmaceutical Preparations